10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING

DOI

10.1016/j.artres.2016.10.081How to use a DOI?

Abstract

Aim: The aim of this study is to evaluate the feasibility of Microlife Watch BP for measuring bilateral blood pressure (BP) in a clinical setting.

Method: 339 patients (85% diabetic) scheduled for ambulatory blood pressure monitoring at the outpatient clinic for endocrinology, Silkeborg Regional Hospital, were examined with simultaneously bilateral BP measurements. A fully automatic, oscillometric device was used and two successive measurements were made.

Results: 9,1% of the patients had a clinically significant inter-arm blood pressure difference (IAD) of ≥10mmHg in the first set of measurements. Mean IAD in the first measurement was -0,3mmHg 6.6. Twenty-three patients had a normal IAD in the first set of measurements but IAD ≥10mmHg in the second set of measurements. Only one of the patients with an IAD ≥10mmHg had a change in the arm with the highest blood pressure. The 95 % Limits of Agreement (LoA) for the mean interarm difference for a single measurement was 13.2 mmHg.

Conclusion: Microlife WatchBP measurement is a feasible method to determine IAD in a clinical setting. Bilateral BP measurements should be performed at first visit to help the clinician choose the right arm for further BP evaluations.

Open Access

This is an open access article distributed under the CC BY-NC license.

TY  - JOUR
AU  - Christoffer Krogager
AU  - Esben Laugesen
AU  - Niklas B. Rossen
AU  - Per L. Poulsen
AU  - Mogens Erlandsen
AU  - Klavs W. Hansen
PY  - 2016
DA  - 2016/11/24
TI  - 10.3 USE OF MICROLIFE BP WATCH IS A FEASIBLE APPROACH TO DETERMINE INTER-ARM BLOOD PRESSURE DIFFERENCES IN A CLINICAL SETTING
JO  - Artery Research
SP  - 71
EP  - 72
VL  - 16
IS  - C
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2016.10.081
DO  - 10.1016/j.artres.2016.10.081
ID  - Krogager2016
ER  -